Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TRIM24 mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. Additionally we are shipping TRIM24 Proteins (7) and and many more products for this protein.
Showing 10 out of 124 products:
Human Polyclonal TRIM24 Primary Antibody for IP, WB - ABIN251037
Levin, Panchabhai, Shen, Kornblau, Qiu, Baggerly: Different changes in protein and phosphoprotein levels result from serum starvation of high-grade glioma and adenocarcinoma cell lines. in Journal of proteome research 2010
Show all 4 Pubmed References
Human Monoclonal TRIM24 Primary Antibody for IF, IHC (p) - ABIN563797
Kikuchi, Okumura, Tsukiyama, Watanabe, Miyajima, Tanaka, Imamura, Hatakeyama: TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. in Biochimica et biophysica acta 2009
Show all 3 Pubmed References
Human Polyclonal TRIM24 Primary Antibody for ICC, IF - ABIN251036
Allton, Jain, Herz, Tsai, Jung, Qin, Bergmann, Johnson, Barton: Trim24 targets endogenous p53 for degradation. in Proceedings of the National Academy of Sciences of the United States of America 2009
Show all 3 Pubmed References
Human Polyclonal TRIM24 Primary Antibody for IHC (p), IHC - ABIN268590
Thénot, Henriquet, Rochefort, Cavaillès: Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. in The Journal of biological chemistry 1997
Human Polyclonal TRIM24 Primary Antibody for ICC, IF - ABIN4359700
Theurillat, Udeshi, Errington, Svinkina, Baca, Pop, Wild, Blattner, Groner, Rubin, Moch, Privé, Carr, Garraway: Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. in Science (New York, N.Y.) 2014
these results suggested that TRIM24 has an important role in the growth of Nasopharyngeal carcinoma (NPC (show NPC1 Antibodies)). Additionally, silenced TRIM24 may lead to inhibited cell proliferation and induced cell apoptosis in NPC (show NPC1 Antibodies) cells.
TRIM24 is upregulated in HNSCC and promotes HNSCC cell growth and invasion through modulation of cell cycle, glucose metabolism, and GLUT3 (show SLC2A3 Antibodies), making TRIM24 a potential oncoprotein in HNSCC.
The findings identify TRIM24 as an oncogenic transcriptional co-activator in epidermal growth factor receptor (show EGFR Antibodies)-driven glioblastoma and also demonstrate a previously unknown signal relay by which H3K23ac/TRIM24 mediates epidermal growth factor receptor (show EGFR Antibodies) stimulation of STAT3 (show STAT3 Antibodies) activation, thereby enhancing the oncogenic activity of the epidermal growth factor receptor (show EGFR Antibodies)/STAT3 (show STAT3 Antibodies) pathway in human cancers.
Results suggest that TRIM24 is a novel coactivator of the CAR that is involved in cell- and/or promoter- selective transactivation.
TRIM24 expression was increased in human colorectal cancer and might be a novel prognostic biomarker.
Study showed that TRIM24 was upregulated during gastric carcinogenesis and demonstrated that TRIM24 was a functional target gene of miR (show MLXIP Antibodies)-511, and miR (show MLXIP Antibodies)-511 inactivated PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies) and Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) pathways by suppressing TRIM24.
Overexpression of KAT6A (show MYST3 Antibodies) or TRIM24 promoted PIK3CA (show PIK3CA Antibodies) expression, AKT (show AKT1 Antibodies) phosphorylation, and cell proliferation.
we identified altered glucose metabolism in the progression of head and neck squamous cell carcinoma and showed that it could be partially attributed to the novel link between GLUT4 (show SLC2A4 Antibodies) and TRIM24
This study concluded that reduced TRIM24 protein is associated with poor survival in esophageal squamous cell cancer (ESCC) patients, suggesting TRIM24 protein is a potential prognostic biomarker for ESCC.
Data suggest that, in cardiomyocytes, TRIM32 attenuates activation of SRF signaling and hypertrophy due to dysbindin; TRIM24 promotes these effects. TRIM32 promotes dysbindin degradation; TRIM24 protects dysbindin from degradation. (TRIM = tripartite motif-containing protein; SRF = serum response factor)
Maintenance of pluripotency is regulated by a network of transcription factors coordinated by Oct4 (show POU5F1 Antibodies), Sox2 (show SOX2 Antibodies), and Nanog (show NANOG Antibodies); Trim24 significantly improved efficiency of cellular reprogramming, demonstrating its direct functionality in establishing pluripotency.
data identify a previously unappreciated Trim24-dependent requirement for IL-1R expression on TH2 cells and an important nonredundant role for T-cell-intrinsic Trim24 in TH2-mediated allergy and antihelminth immunity
Trim24 repressed VL30-class endogenous retroviruses retrotransposons
These results identify Trim24 as a novel negative regulator of the IFN/STAT (show STAT1 Antibodies) pathway and suggest that this repression through Rara (show RARA Antibodies) inhibition may prevent liver cancer.
Somatic hepatocyte-specific inactivation of TRIM24, TRIM28 (show TRIM28 Antibodies), or TRIM33 (show TRIM33 Antibodies) all promote hepatocellular carcinoma in a cell-autonomous manner in mice.
TRIM24 regulates AR-mediated transcription in collaboration with TIP60 (show KAT5 Antibodies) and BRD7 (show BRD7 Antibodies).
TIF1alpha-chromatin association is direct and involves DNA and nucleosome interactions mediated by the bromodomain
These studies indicate that TIF1alpha is a factor that modulates the expression of a set of genes during the first wave of genome activation in the mouse embryo.
The results not only provide genetic evidence that Trim24 and Rara (show RARA Antibodies) co-regulate hepatocarcinogenesis in an antagonistic manner but also suggest that aberrant activation of Rara (show RARA Antibodies) is deleterious to liver homeostasis.
TIF1alpha-null mutant pathological phenotype supports the hypothesis that aging is promoted by increased activity of the vitamin D signaling pathway
The protein encoded by this gene mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. The protein localizes to nuclear bodies and is thought to associate with chromatin and heterochromatin-associated factors. The protein is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains - a RING, a B-box type 1 and a B-box type 2 - and a coiled-coil region. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene.
tripartite motif-containing 24
, transcriptional intermediary factor 1 alpha
, tripartite motif containing 24
, E3 ubiquitin-protein ligase TRIM24
, RING finger protein 82
, transcription intermediary factor 1-alpha
, transcriptional intermediary factor 1
, E3 ubiquitin-protein ligase Trim24
, transcriptional intermediary factor 1, alpha
, tripartite motif-containing protein 24